Medical cannabis clinics owner-operator Empower Clinics has entered into an agreement with Titration Technologies LLC, an innovator in cannabis product development, to manufacture, package, and fulfill Empower’s “Sollievo” CBD medical cannabis products throughout North America.
Empower’s Sollievo (Italian for “relief”) products specifically target the most common qualifying medical conditions, involving pain, sleep, stress, and digestion. The products, available as tinctures or topical creams, are non-THC CBD, meaning that they are non-psychotropic: they do not directly affect mood, perception, or consciousness.
As part of the agreement, Titration will produce Empower-formulated CBD medical cannabis products, which Empower will sell under its “Sollievo” product brand on Empower’s website, at Empower clinics, as well as select third-party wellness clinics throughout the US and Canada.
“This agreement enables patients in all 50 states and Canada to access Empower’s CBD products, which is an important milestone as we continue to expand our business and service areas,” says Craig Snyder, Empower CEO, in a release. “As we grow our footprint of medical cannabis and wellness clinics, product sales are an important market channel and revenue stream for us. We are excited to be working with a proven leader like Titration and their team of respected plant scientists.”
Under the agreement, Titration will provide product manufacturing, packaging, warehousing, and fulfillment for Empower.
“Empower has been rapidly building its business and we are looking forward to working with them in providing a superior line of CBD products,” says Jason Sonchik, Titration director of quality control.
Last month, Empower Clinics announced the opening of a Chicago clinic as well as a clinic expansion strategy.
